Menu
Home
Forums
New posts
Search forums
What's new
New posts
New profile posts
Latest activity
Members
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Everywhere
Threads
This forum
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Home
Forums
Forum Diskusi Untuk Umum
Isu Terkini Seputar Farmakologi
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Info Obat dan Regulator Obat Dunia
Prev
1
…
Go to page
Go
66
67
68
69
70
…
Go to page
Go
126
Next
First
Prev
68 of 126
Go to page
Go
Next
Last
Filters
Show only:
Loading…
F
Dermatologic and Ophthalmic Drugs Advisory Committee Roster
FDA
Sep 13, 2022
Replies
0
Views
275
Sep 13, 2022
FDA
F
F
Generic Competition and Drug Prices
FDA
Sep 13, 2022
Replies
0
Views
233
Sep 13, 2022
FDA
F
F
Statement of Identity and Strength — Content and Format of Labeling for Human Nonprescription Drug Products
FDA
Sep 10, 2022
Replies
0
Views
542
Sep 10, 2022
FDA
F
F
FDA draft guidance aims to improve consistency of labeling for nonprescription drugs
FDA
Sep 10, 2022
Replies
0
Views
264
Sep 10, 2022
FDA
F
F
Registered Outsourcing Facilities
FDA
Sep 10, 2022
Replies
0
Views
277
Sep 10, 2022
FDA
F
F
Submitting Documents Using Real-World Data and Real-World Evidence to FDA for Drug and Biological Products
FDA
Sep 10, 2022
Replies
0
Views
347
Sep 10, 2022
FDA
F
E
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 6-8 September 2022, CVMP, 09/09/2022
EMA
Sep 10, 2022
Replies
0
Views
331
Sep 10, 2022
EMA
E
F
2020 Meeting Materials, Cardiovascular and Renal Drugs Advisory Committee
FDA
Sep 8, 2022
Replies
0
Views
215
Sep 8, 2022
FDA
F
F
2019 Meeting Materials, Cardiovascular and Renal Drugs Advisory Committee
FDA
Sep 8, 2022
Replies
0
Views
236
Sep 8, 2022
FDA
F
F
Cardiovascular and Renal Drugs Advisory Committee Charter
FDA
Sep 8, 2022
Replies
0
Views
249
Sep 8, 2022
FDA
F
F
2019 Meeting Materials, Pulmonary-Allergy Drugs Advisory Committee
FDA
Sep 8, 2022
Replies
0
Views
242
Sep 8, 2022
FDA
F
F
2020 Meeting Materials, Pulmonary-Allergy Drugs Advisory Committee
FDA
Sep 8, 2022
Replies
0
Views
217
Sep 8, 2022
FDA
F
F
General Clinical Pharmacology Considerations for Pediatric Studies of Drugs, Including Biological Products
FDA
Sep 8, 2022
Replies
0
Views
293
Sep 8, 2022
FDA
F
F
Fluorouracil and Pet Safety
FDA
Sep 8, 2022
Replies
0
Views
249
Sep 8, 2022
FDA
F
F
CDER and CBER accept first submission to ISTAND Pilot Program
FDA
Sep 8, 2022
Replies
0
Views
264
Sep 8, 2022
FDA
F
E
Have your say on EMA’s communications – how are we doing?, , 01/09/2022
EMA
Sep 8, 2022
Replies
0
Views
429
Sep 8, 2022
EMA
E
E
First adapted COVID-19 booster vaccines recommended for approval in the EU, CHMP, 01/09/2022
EMA
Sep 8, 2022
Replies
0
Views
283
Sep 8, 2022
EMA
E
E
New measures to minimise risk of meningioma with medicines containing nomegestrol or chlormadinone, CHMP, 02/09/2022
EMA
Sep 8, 2022
Replies
0
Views
330
Sep 8, 2022
EMA
E
E
PRAC starts review of topiramate use in pregnancy and women of childbearing potential, PRAC, 02/09/2022
EMA
Sep 8, 2022
Replies
0
Views
344
Sep 8, 2022
EMA
E
E
Accelerating Clinical Trials in the EU: publication of 2022-2026 workplan, , 30/08/2022
EMA
Sep 8, 2022
Replies
0
Views
253
Sep 8, 2022
EMA
E
Prev
1
…
Go to page
Go
66
67
68
69
70
…
Go to page
Go
126
Next
First
Prev
68 of 126
Go to page
Go
Next
Last
You must log in or register to post here.
Home
Forums
Forum Diskusi Untuk Umum
Isu Terkini Seputar Farmakologi
Top